Metabolic indicators, including triglyceride-glucose index, TG, and RC, were associated with an increased risk for hypothyroidism.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

Prolonged or heavy menstrual bleeding during the menopause transition is associated with experiencing certain symptoms of fatigue.

The likelihood of achieving target T-scores at the total hip and lumbar spine with denosumab depends on baseline BMD in postmenopausal women with osteoporosis.

Topline data were announced from a phase 3 trial evaluating eneboparatide in adults with chronic hypoparathyroidism.

Consuming a more anti-inflammatory diet may modulate systemic and metabolic inflammation, potentially reducing gout risk and its life-threatening comorbidities, particularly for women, who are ...